Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pangramin Depot UM
- Development stage
- Preclinical
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
**Pangramin Depot UM** is a biologically standardized **depot allergen immunotherapy extract** derived from *Dermatophagoides pteronyssinus* house-dust mite and adsorbed onto **aluminum hydroxide** for sustained subcutaneous administration. It was used as a therapeutic desensitization product in patients with respiratory allergy, including perennial rhinitis and mild to moderate bronchial asthma, with quantified major allergens **Der p 1** and **Der p 2**. Its therapeutic effect is based on **allergen-specific immunotherapy**, in which repeated exposure to mite allergens aims to induce immune tolerance and reduce IgE-mediated hypersensitivity symptoms rather than directly blocking a single receptor or enzyme. The cited publication supports use in house-dust mite allergy, but the specific commercial developer and manufacturer are not clearly identifiable from the provided source alone.
- Brand names
- Pangramin Depot UM
- Other names
- Dermatophagoides pteronyssinus depot allergen extractD. pteronyssinus depot extracthouse-dust mite allergen extract
02
Targets
Der p 2 (Dermatophagoides pteronyssinus allergen 2)Der p 1 (Dermatophagoides pteronyssinus allergen 1)
Beyond the preview
Go deeper on Pangramin Depot UM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pangramin Depot UM.